Chris Lewis has had a successful career in the medical and clinical field, holding various leadership positions in companies such as Balt, VectivBio AG, Intersect ENT, Novella Clinical, Global Institute for Research, Abbott Vascular, Amgen, and Novartis. With a Master's degree in Clinical Administration from The George Washington University School of Medicine and Health Sciences, and a Bachelor's degree in Biology from the University of Louisiana Monroe, Chris has a strong educational background to support their extensive experience in clinical operations and medical affairs.
Org chart
Teams
Offices
This person is not in any offices
Balt
1 followers
We are Balt. Physician-inspired innovations. Patient-focused solutions. For 45 years, Balt has been leading the way – collaborating with physicians and institutions to develop elegant neurovascular solutions. As the premier global neurovascular platform, always seeking to expand beyond boundaries, we are now bringing our innovation to the peripheral vascular space. We introduced the first neurovascular intervention device in 1977. Now, we offer the world’s broadest portfolio of medical devices for ischemic and hemorrhagic stroke, as well as devices for peripheral embolization. In 2015, we embarked on an ambitious journey and quadrupled our revenue and workforce, and that was only the beginning. Now, the Balt family includes more than 700 talented team members at 13 sites in 11 countries around the world. Be a part of our future: www.baltgroup.com
